We report three cases of children with osteosarcoma and pathologic fractures treated with long-term continuous nerve blocks for preoperative pain control.
Osteosarcoma accounts for 5% of childhood cancers and is the most common paediatric primary malignancy of the bone 1 . Fractures occur in 5 to 10% of cases, either spontaneously or after minor trauma 2 . One of the most troublesome symptoms of pathologic fractures is pain 3, 4 and therefore pain control is an important component of treating patients with pathologic fractures.
These patients usually complete at least 10 to 12 weeks of chemotherapy prior to undergoing a limbsparing surgical procedure or an amputation. During this preoperative period, continuous nerve blocks (CNB) may provide analgesia while the fracture heals and can potentially be removed after the fracture is stabilised and pain is minimal. Because data on the long-term use of CNBs in paediatric patients are somewhat limited, we describe our experience in three cases with pathological fractures and review the relevant literature, particularly with regard to infectious complications. Additionally, we present data regarding our three patients' demographics, diagnoses and quality of analgesia obtained with the nerve block placement expressed as pain scores and as use of systemic opioid (morphine equivalent, mg/kg/day) in Table 1 . Administration of antibiotics was noted, with the exception of trimethoprim and sulfamethoxazole which are routinely prescribed as prophylaxis for Pneumocystis carinii and ordered on a thrice-weekly schedule.
Permission to publish the reports was obtained from the parents of two patients. One family of a deceased child was not contactable. Our institutional review board approved publication of all three reports.
CASE REPORTS Case 1
A 14-year-old African-American boy first presented with left thigh pain and intermittent swelling. A plain radiograph showed gross abnormality of the left femoral shaft, and subsequent magnetic resonance imaging (MRI) showed a mass extending from the greater trochanter to the distal metaphysis.
Open biopsy confirmed the diagnosis of high-grade osteosarcoma. Subsequent scans including computed tomography of the chest showed no evidence of metastatic disease.
After undergoing an initial course of chemotherapy, the patient sustained a pathologic fracture through the distal femoral diaphysis while he was an outpatient. He was admitted to the hospital for placement of a cast and pain control. A tunnelled femoral catheter was inserted while the patient was under general anaesthesia and a continuous infusion of 0.2% ropivacaine (10 ml/hour) was initiated. The patient also received oral gabapentin and opioids (Table 1) . He was discharged from the hospital and the CNB was maintained in the outpatient setting for 26 of 41 days. The CNB was removed when pain had been sufficiently controlled. Antibiotics with Staphylococcus and Streptococcus coverage (ceftriaxone, meropenem, [and/or] vancomycin) were given 14 of 41 days. Two months later the patient underwent en bloc resection of the tumour and placement of a total femoral prosthesis.
Case 2
A 13-year-old African-American girl presented with severe left hip pain after a one year history of mild pain. The MRI showed an extensive noncystic, heterogeneously enhancing lesion involving the proximal left femoral shaft, with extraosseous extension and pathologic fracture. An open biopsy confirmed the diagnosis of osteosarcoma and a chest computed tomography revealed multiple pulmonary nodules. The patient was admitted and placed in skeletal traction.
The patient received a single femoral nerve block injection (0.25% bupivacaine, 20 mL) to facilitate positioning for an MRI scan and experienced almost total pain relief. A tunnelled femoral catheter was placed the following day and a continuous infusion of 0.2% ropivacaine (6 ml/hour) was started.
The CNB catheter was replaced after 33 days due to catheter obstruction. The second femoral catheter was removed for an MRI study 26 days later and was replaced the following day. The third CNB catheter was removed 22 days later for an MRI study. Because the patient was experiencing only minimal pain, the continuous peripheral nerve block was not replaced. Antibiotics that provided coverage against Staphylococcus and Streptococcus species (ampicillin, cefepime and/or cefuroxime) were administered on 23 of 83 days. The patient underwent left hip disarticulation five days after removal of the third CNB.
Case 3
Telangiectatic osteosarcoma was diagnosed in an eight-year-old African-American girl after she fractured her right humerus during a fall. An MRI showed a large tumour involving the proximal half of the humerus with the presence of a pathologic fracture and extensive soft-tissue involvement. A tunnelled catheter for CNB was inserted into the brachial plexus via an interscalene approach, and an infusion of 0.2% ropivacaine (6 ml/hour) was initiated. The patient was discharged a week later with the catheter in situ and continued to have good pain control.
After 36 days, the use of analgesia for breakthrough pain was minimal and an MRI was planned, so the catheter was removed. Of those 36 days, 24 were as an outpatient. Antibiotics with coverage against Staphylococcus and Streptococcus species (ceftriaxone and/or clindamycin) were given on seven of 36 days. Forequarter amputation was carried out two months later.
DISCUSSION
We present three children with pathologic fractures secondary to osteosarcoma whose pain was managed preoperatively with CNBs for prolonged periods. The catheter insertion procedures have been described elsewhere, as has the tunnelling technique 5 . Patients with osteosarcoma receive chemotherapy for at least 10 to 12 weeks prior to the surgical intervention; in our cases the longest duration for a CNB catheter was 41 days. Although one patient remained hospitalised for skeletal traction, the other two were also successfully treated with CNBs as outpatients.
Pain management aims to maximise analgesia, maintain the patient's ability to ambulate and minimise side-effects. The World Health Organization Pain Relief Ladder for Cancer Pain advocates the use of medications of increasing potency from nonopioids (e.g. acetaminophen, nonsteroidal antiinflammatory drugs) for mild pain to opioids (e.g. morphine) for severe pain 6 . In some patients however, even opioids do not provide adequate pain relief 6 and may be associated with unacceptable side-effects 6 . As an alternative or adjunct to the medications described, pain management in patients with cancer may include epidural analgesia 6 , but this approach may limit ambulation and necessitate the placement of a urinary catheter 7 , which may be undesirable.
In recent years, CNBs have begun to play an important role in paediatric postoperative pain control 8 . Their potential benefits include earlier ambulation, improved outpatient pain management, fewer complications and reduced opioid-related sideeffects 9 . Although the safety and efficacy of CNBs including outpatient use 10 has been reported in paediatric patients 8 , most reports pertain to their use for postoperative pain control 7, 8, 10, 11 . There are limited reports on the use of this technique for other indications in children 12, 13 , including the use of longterm CNB catheters for palliative pain control at the end of life 14 .
We found analgesic efficacy as reflected by decreased mean daily pain scores and decreased opioid requirement (mg/kg/day) at 24 hours in two and one case respectively and at 48 hours in all three cases in our case series ( Table 1 ). The key concern of prolonged CNB use is infection. Despite the extended duration of CPNB catheters and the fact that our patients may have had some degree of immunosuppression due to chemotherapy, none experienced a catheter-related infection. Factors contributing to this outcome may have been the subcutaneous tunnelling of the catheters and, in one case, administration of prophylactic antibiotics ( Table 1) .
Subcutaneous tunnelling may reduce the risk of catheter infection because catheter-related infections usually arise from bacteria on the skin at the catheter insertion site 15, 16, 17 . This method, used in all three of our cases, aims to increase the distance between the catheter insertion site and the nerve 18 . In a study of tunnelled nerve blocks, the bacterial colonisation rate was only 6.2% 18 which is substantially better than the range of 17 to 57% reported in studies in which tunnelling was not used 16, 19, 20 . This theory is further supported by recent reports in which tunnelling was not used and acute neck cellulitis and psoas abscess occurred following nerve block placement 15, 16, 21, 22 .
Prophylactic antibiotics may reduce the risk of infection and inflammation associated with CNBs 16, 20 . In a study of 405 brachial plexus catheters, only one superficial axillary infection occurred and that was in a patient who did not receive antibiotic therapy for two days 23 . Similarly, in a case of fatal infection after a brachial plexus block, no antibiotics were used and the authors hypothesised that the serious adverse event may have been avoided if antibiotic therapy had been given 22 .
In large studies of CNB catheters, the organisms most often cultivated from catheter tips are Staphylococcus species 16, 17 . In cases involving clinical infections, Staphylococcus and Streptococcus species have been cultured 15, 16, 21, 22, 23 . The patients in our report received antibiotics that covered these organisms on 4.5 to 51.5% of the days that the continuous peripheral nerve block catheters were in situ (Table 1) 
for various clinical indications that
were not thought to be related to the continuous peripheral nerve block catheter.
In summary, we present three cases of extended use of CNBs for painful pathologic fractures in children with osteosarcoma. Pain was successfully managed, as indicated by decreases in mean daily pain scores and daily opioid requirements at 48 hours after block placement. Pain was also managed in the outpatient setting in two of the three patients intermittently for several weeks. The problems we encountered were incompatibility with the MRI scanner and catheter occlusion. We suggest that subcutaneous tunnelling prevents infectious complications and that prophylactic antibiotics directed toward gram-positive organisms should be considered.
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